查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146002

全球骨轉移診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Bone Metastatic Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 155 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球骨轉移診斷市場預計將從2025年的202.8億美元成長至2034年的418.1億美元，2026年至2034年的複合年成長率（CAGR）為8.37%。這項市場擴張主要得益於醫療專業人員日益重視癌症患者骨轉移的早期檢測和後續觀察。骨轉移診斷有助於癌症分期、治療方案製定和療效評估。癌症發生率的不斷上升以及人們對轉移相關併發症認知的不斷提高，推動了對影像和診斷技術的需求。醫院和腫瘤中心正在採用先進的診斷技術，以提供更詳細的骨骼侵犯訊息，從而做出更準確的臨床決策，並幫助醫生更好地管理患有複雜轉移性疾病的患者。

這一成長得益於醫學影像技術的進步、癌症篩檢的普及以及診斷準確性的提高。 PET、MRI、CT、骨骼掃描和分子影像等技術正根據臨床需求得到應用。此外，標靶造影劑的研發透過更特異性識別轉移性病灶，拓展了診斷能力。對癌症治療基礎設施和多學科腫瘤診療服務的投入增加，進一步促進了這些技術的應用。影像處理和人工智慧（AI）技術的進步也有助於提高影像解讀能力，幫助臨床醫生識別細微異常。

隨著癌症治療日益個人化，並依賴對疾病特徵的精準理解，前景依然樂觀。分子和混合成像技術有望提供更多關於腫瘤生物學特徵及其治療反應的資訊。人工智慧可望輔助自動影像分析、病灶檢測和診斷決策。新興市場癌症治療基礎設施的擴展，以及先進影像診斷技術的普及，可望創造更多機會。能夠將診斷準確性、高效的工作流程、互通性和成本效益技術相結合的醫療機構，將能夠更好地從轉移性癌症管理的不斷發展中獲益。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球骨轉移診斷市場：按類型分類

  • 市場分析、洞察與預測
  • 溶骨性骨轉移
  • 成骨細胞性骨轉移
  • 混合型骨轉移

第5章 全球骨轉移診斷市場：依診斷方法分類

  • 市場分析、洞察與預測
  • 切片檢查
  • 驗血
  • 診斷影像

第6章 全球骨轉移診斷市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心

第7章 全球骨轉移診斷市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • General Electric Company
    • Koninklijke Philips NV
    • Siemens Healthcare GmbH
    • Carestream Health
    • FUJIFILM Corporation
    • Canon Medical Systems
    • Hitachi Ltd
    • Brainlab AG
    • Varian Medical Systems
簡介目錄
Product Code: VMR112115230

The global bone metastatic diagnostics market size is expected to reach USD 41.81 Billion in 2034 from USD 20.28 Billion in 2025, growing at a CAGR of 8.37% during 2026-2034.This market is growing as healthcare providers increasingly focus on earlier identification and monitoring of bone metastases in cancer patients. Bone metastatic diagnostics support disease staging, treatment planning, and assessment of therapeutic response. Growing cancer incidence and improved awareness of metastatic complications are increasing demand for imaging and diagnostic technologies. Hospitals and oncology centers are adopting advanced diagnostic approaches that can provide more detailed information about skeletal involvement, supporting more informed clinical decisions and helping physicians manage patients with complex metastatic disease.

Growth is being driven by advances in medical imaging, increasing oncology screening, and improvements in diagnostic accuracy. Technologies such as PET, MRI, CT, bone scintigraphy, and molecular imaging are being used according to clinical requirements. The development of targeted imaging agents is also expanding diagnostic capabilities by enabling more specific identification of metastatic lesions. Increasing investment in cancer care infrastructure and multidisciplinary oncology services is further supporting adoption. Improvements in image processing and artificial intelligence may also enhance interpretation and help clinicians identify subtle abnormalities.

Future prospects remain favorable as oncology care becomes increasingly personalized and dependent on accurate disease characterization. Molecular imaging and hybrid imaging technologies could provide additional information about tumor biology and treatment response. Artificial intelligence may support automated image analysis, lesion detection, and diagnostic decision-making. Expanding cancer care infrastructure in emerging markets can create additional opportunities as access to advanced imaging improves. Providers that combine diagnostic accuracy, efficient workflows, interoperability, and cost-effective technologies will be positioned to benefit from the continuing evolution of metastatic cancer management.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Osteolytic Bone Metastasis
  • Osteoblastic Bone Metastasis
  • Mixed Bone Metastasis

By Diagnosis

  • Biopsy
  • Blood Test
  • Imaging

By End User

  • Hospitals
  • Ambulatory Surgical Centers

COMPANIES PROFILED

  • General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, Carestream Health, FUJIFILM Corporation, Canon Medical Systems, Hitachi Ltd., Brainlab AG, Varian Medical Systems

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Osteolytic Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Osteoblastic Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Mixed Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY DIAGNOSIS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Diagnosis
  • 5.2. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Blood Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Diagnosis
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Diagnosis
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Spain
    • 7.3.9 Russia
    • 7.3.10 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Diagnosis
    • 7.4.3 By End User
    • 7.4.4 China
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 India
    • 7.4.8 Australia
    • 7.4.9 South East Asia
    • 7.4.10 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Diagnosis
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Diagnosis
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BONE METASTATIC DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 General Electric Company
    • 9.2.2 Koninklijke Philips N.V
    • 9.2.3 Siemens Healthcare GmbH
    • 9.2.4 Carestream Health
    • 9.2.5 FUJIFILM Corporation
    • 9.2.6 Canon Medical Systems
    • 9.2.7 Hitachi Ltd
    • 9.2.8 Brainlab AG
    • 9.2.9 Varian Medical Systems